Can Tailored Patient Letters Improve The Quality Of Diabetic Patient Care?

NCT00984841 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 467

Last updated 2009-09-25

No results posted yet for this study

Summary

The purpose of this study is to determine if tailored letters sent to diabetic patients will improve care of diabetes.

Conditions

Interventions

OTHER

Tailored letter

Sponsors & Collaborators

  • Scranton-Temple Residency Program

    lead OTHER

Principal Investigators

  • John R Guzek, MD · Scranton-Temple Residency Program

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2009-04-30
Completion
2009-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00984841 on ClinicalTrials.gov